These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cytochrome P-450 isozyme/isozyme functional interactions and NADPH-cytochrome P-450 reductase concentrations as factors in microsomal metabolism of warfarin. Kaminsky LS, Guengerich FP. Eur J Biochem; 1985 Jun 18; 149(3):479-89. PubMed ID: 3924614 [Abstract] [Full Text] [Related]
3. Chemical synthesis, absolute configuration, and stereochemistry of formation of 10-hydroxywarfarin: a major oxidative metabolite of (+)-(R)-warfarin from hepatic microsomal preparations. Lawrence RF, Rettie AE, Eddy AC, Trager WF. Chirality; 1990 Jun 18; 2(2):96-105. PubMed ID: 2400642 [Abstract] [Full Text] [Related]
4. Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes. Beaune PH, Kremers PG, Kaminsky LS, De Graeve J, Albert A, Guengerich FP. Drug Metab Dispos; 1986 Jun 18; 14(4):437-42. PubMed ID: 2873991 [Abstract] [Full Text] [Related]
5. Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450. Miller KK, Cai J, Ripp SL, Pierce WM, Rushmore TH, Prough RA. Drug Metab Dispos; 2004 Mar 18; 32(3):305-13. PubMed ID: 14977864 [Abstract] [Full Text] [Related]
7. Comparisons of warfarin metabolism by liver microsomes of rats treated with a series of polybrominated biphenyl congeners and by the component-purified cytochrome P-450 isozymes. Kaminsky LS, Guengerich FP, Dannan GA, Aust SD. Arch Biochem Biophys; 1983 Aug 18; 225(1):398-404. PubMed ID: 6311109 [Abstract] [Full Text] [Related]
8. Genetic and developmental diversity of hepatic cytochromes P450. Warfarin and progesterone metabolism by hepatic microsomes from four inbred strains of rat. Kitareewan S, Walz FG. Drug Metab Dispos; 1994 Aug 18; 22(4):607-15. PubMed ID: 7956737 [Abstract] [Full Text] [Related]
11. Stereoselective metabolism of cisapride and enantiomer-enantiomer interaction in human cytochrome P450 enzymes: major role of CYP3A. Desta Z, Soukhova N, Morocho AM, Flockhart DA. J Pharmacol Exp Ther; 2001 Aug 18; 298(2):508-20. PubMed ID: 11454912 [Abstract] [Full Text] [Related]
12. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone. Takahashi H, Sato T, Shimoyama Y, Shioda N, Shimizu T, Kubo S, Tamura N, Tainaka H, Yasumori T, Echizen H. Clin Pharmacol Ther; 1999 Dec 18; 66(6):569-81. PubMed ID: 10613612 [Abstract] [Full Text] [Related]
13. Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe. Kaminsky LS, de Morais SM, Faletto MB, Dunbar DA, Goldstein JA. Mol Pharmacol; 1993 Feb 18; 43(2):234-9. PubMed ID: 8429826 [Abstract] [Full Text] [Related]
14. Warfarin: stereochemical aspects of its metabolism in vivo in the rat. Pohl LR, Bales R, Trager WF. Res Commun Chem Pathol Pharmacol; 1976 Oct 18; 15(2):233-56. PubMed ID: 981784 [Abstract] [Full Text] [Related]
16. Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics. Hermans JJ, Thijssen HH. Br J Pharmacol; 1993 Sep 18; 110(1):482-90. PubMed ID: 8220911 [Abstract] [Full Text] [Related]
17. In vitro biotransformation and identification of human cytochrome P450 isozyme-dependent metabolism of tazofelone. Surapaneni SS, Clay MP, Spangle LA, Paschal JW, Lindstrom TD. Drug Metab Dispos; 1997 Dec 18; 25(12):1383-8. PubMed ID: 9394028 [Abstract] [Full Text] [Related]